Comparison of endoscopic gastritis based on Kyoto classification between diffuse and intestinal gastric cancer

BACKGROUND Gastric cancers can be categorized into diffuse- and intestinal-type cancers based on the Lauren histopathological classification. These two subtypes show distinct differences in metastasis frequency, treatment application, and prognosis. Therefore, accurately assessing the Lauren classification before treatment is crucial. However, studies on the gastritis endoscopy-based Kyoto classification have recently shown that endoscopic diagnosis has improved. AIM To investigate patient characteristics including endoscopic gastritis associated with diffuse- and intestinal-type gastric cancers in Helicobacter pylori (H. pylori)-infected patients. METHODS Patients who underwent esophagogastroduodenoscopy at the Toyoshima Endoscopy Clinic were enrolled. The Kyoto classification included atrophy, intestinal metaplasia, enlarged folds, nodularity, and diffuse redness. The effects of age, sex, and Kyoto classification score on gastric cancer according to the Lauren classification were analyzed. We developed the Lauren predictive background score based on the coefficients of a logistic regression model using variables independently associated with the Lauren classification. Area under the receiver operative characteristic curve and diagnostic accuracy of this score were examined. RESULTS A total of 499 H. pylori-infected patients (49.6% males; average age: 54.9 years) were enrolled; 132 patients with gastric cancer (39 diffuse- and 93 intestinal-type cancers) and 367 cancer-free controls were eligible. Gastric cancer was independently associated with age ≥ 65 years, high atrophy score, high intestinal metaplasia score, and low nodularity score when compared to the control. Factors independently associated with intestinal-type cancer were age ≥ 65 years (coefficient: 1.98), male sex (coefficient: 1.02), high intestinal metaplasia score (coefficient: 0.68), and low enlarged folds score (coefficient: -1.31) when compared to diffuse-type cancer. The Lauren predictive background score was defined as the sum of +2 (age ≥ 65 years), +1 (male sex), +1 (endoscopic intestinal metaplasia), and -1 (endoscopic enlarged folds) points. Area under the receiver operative characteristic curve of the Lauren predictive background score was 0.828 for predicting intestinal-type cancer. With a cut-off value of +2, the sensitivity, specificity, and accuracy of the Lauren predictive background score were 81.7%, 71.8%, and 78.8%, respectively. CONCLUSION Patient backgrounds, such as age, sex, endoscopic intestinal metaplasia, and endoscopic enlarged folds are useful for predicting the Lauren type of gastric cancer.

[1]  C. Tanikawa,et al.  Endoscopy-based Kyoto classification score of gastritis related to pathological topography of neutrophil activity , 2020, World journal of gastroenterology.

[2]  C. Tanikawa,et al.  The simplified Kyoto classification score is consistent with the ABC method of classification as a grading system for endoscopic gastritis , 2020, Journal of clinical biochemistry and nutrition.

[3]  P. Moayyedi,et al.  Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis , 2020, Gut.

[4]  Shen Xin,et al.  Risk factors of tumor invasion and node metastasis in early gastric cancer with undifferentiated component: a multicenter retrospective study on biopsy specimens and clinical data , 2020, Annals of translational medicine.

[5]  M. Nojima,et al.  Validity of endoscopic features for the diagnosis of Helicobacter pylori infection status based on the Kyoto classification of gastritis , 2020, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[6]  D. Murawa,et al.  Yield of staging laparoscopy in gastric cancer is influenced by Laurén histologic subtype , 2019, Journal of surgical oncology.

[7]  Jong-Lyul Park,et al.  Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer , 2019, Gastric Cancer.

[8]  K. Yokota,et al.  Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication , 2019, Journal of Gastroenterology.

[9]  F. Mégraud,et al.  Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideli , 2019, Endoscopy.

[10]  T. Omori,et al.  Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma , 2019, World Journal of Surgical Oncology.

[11]  J. Ji,et al.  Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  R. Fossmark,et al.  Types of Gastric Carcinomas , 2018, International journal of molecular sciences.

[13]  N. Yamamichi,et al.  Serum anti-Helicobacter pylori antibody titer and its association with gastric nodularity, atrophy, and age: A cross-sectional study , 2018, World journal of gastroenterology.

[14]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[15]  K. Yao,et al.  Clinical predictors of histologic type of gastric cancer. , 2017, Gastrointestinal endoscopy.

[16]  K. Koike,et al.  Association between gastric cancer and the Kyoto classification of gastritis , 2017, Journal of gastroenterology and hepatology.

[17]  Alberto Carmona-Bayonas,et al.  Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry , 2017, British Journal of Cancer.

[18]  O. Inatomi,et al.  Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer , 2017, Internal medicine.

[19]  S. Barni,et al.  Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis. , 2017, Journal of gastrointestinal oncology.

[20]  S. Zeng,et al.  Lauren classification and individualized chemotherapy in gastric cancer , 2016, Oncology letters.

[21]  K. Yao,et al.  Histologic differentiation and mucin phenotype in white opaque substance-positive gastric neoplasias , 2015, Endoscopy International Open.

[22]  K. Yao,et al.  Absent microsurface pattern is characteristic of early gastric cancer of undifferentiated type: magnifying endoscopy with narrow-band imaging. , 2014, Gastrointestinal endoscopy.

[23]  E. Bollschweiler,et al.  Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. , 2014, World journal of gastroenterology.

[24]  Sang Kil Lee,et al.  Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: do we have enough data to support this? , 2014, World journal of gastroenterology.

[25]  Hyojin Park,et al.  Undifferentiated early gastric cancer diagnosed as differentiated histology based on forceps biopsy. , 2013, Pathology, research and practice.

[26]  S. Choi,et al.  Clinical implication of endoscopic gross appearance in early gastric cancer: revisited , 2013, Surgical Endoscopy.

[27]  T. Shimbo,et al.  Endoscopic diagnosis of gastric mucosal activity and inflammation , 2013, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[28]  N. Yamamichi,et al.  Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis , 2012, International journal of cancer.

[29]  H. Jung,et al.  Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high‐incidence region of Korea , 2012, International journal of cancer.

[30]  Yusuke Nakamura,et al.  Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer , 2008, Nature Genetics.

[31]  K. Chayama,et al.  NODULAR GASTRITIS WITH HELICOBACTER PYLORI INFECTION IS STRONGLY ASSOCIATED WITH DIFFUSE‐TYPE GASTRIC CANCER IN YOUNG PATIENTS , 2007 .

[32]  T. Wang,et al.  Inflammation, atrophy, and gastric cancer. , 2007, The Journal of clinical investigation.

[33]  P. Malfertheiner,et al.  Helicobacter pylori and molecular events in precancerous gastric lesions , 2004, Alimentary pharmacology & therapeutics.

[34]  Y. Matsuzawa,et al.  Helicobacter pylori‐induced enlarged‐fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma , 2003, Journal of gastroenterology and hepatology.

[35]  Toshiyuki Matsui,et al.  Novel magnified endoscopic findings of microvascular architecture in intramucosal gastric cancer. , 2002, Gastrointestinal endoscopy.

[36]  T. Yoshimura,et al.  Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989 , 2001, British Journal of Cancer.

[37]  L. Hansson,et al.  Can endoscopic biopsy specimens be used for reliable Laurén classification of gastric cancer? , 1996, Scandinavian journal of gastroenterology.

[38]  G. Olafsdóttir,et al.  Gastric carcinoma: Correlation of diagnosis based on biopsies and resection specimens with reference to the Laurén classification , 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[39]  T. Takemoto,et al.  An Endoscopic Recognition of the Atrophic Border and its Significance in Chronic Gastritis , 1969 .

[40]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[41]  R. P. Blankfield,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.